Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −9.6% | −7.4% | −13.0% | +33.2% | +36.6% | +150.2% | +27.7% | +135.0% | +1,354.8% |
| Peer average | −3.5% | −16.5% | −29.0% | −36.4% | −17.6% | −14.8% | +58.2% | +22.2% | +252.1% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$178 of every $1,000 in BIB is Proshares
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | IQMMProshares Genius MNY MKT ETF | Financial Services | 17.83% | $1,782.56 | 170K | $17.0M |
| 2 | —Net Other Assets (Liabilities) | — | 16.57% | $1,657.40 | 15.8M | $15.8M |
| 3 | GILDGilead Sciences | Healthcare | 6.20% | $620.48 | 35K | $5.9M |
| 4 | AMGNAmgen | Healthcare | 5.55% | $554.87 | 12K | $5.3M |
| 5 | VRTXVertex Pharmaceuticals | Healthcare | 5.29% | $529.34 | 9,419 | $5.1M |
| 6 | REGNRegeneron Pharmaceuticals | Healthcare | 4.21% | $420.59 | 4,246 | $4.0M |
| 7 | MRNAModerna | Healthcare | 3.46% | $345.57 | 17K | $3.3M |
| 8 | BIIBBiogen | Healthcare | 1.63% | $163.40 | 6,204 | $1.6M |
| 9 | RVMDRevolution Medicines | Healthcare | 1.51% | $150.67 | 8,999 | $1.4M |
| 10 | ILMNIllumina | Healthcare | 1.39% | $139.49 | 6,340 | $1.3M |
| 11 | RPRXRoyalty Pharma | Healthcare | 1.34% | $134.49 | 19K | $1.3M |
| 12 | ROIVRoivant Sciences | Healthcare | 1.23% | $123.05 | 30K | $1.2M |
| 13 | INSMInsmed | Healthcare | 1.15% | $115.06 | 9,168 | $1.1M |
| 14 | ARGXArgenx SE | Healthcare | 1.13% | $113.00 | 1,146 | $1.1M |
| 15 | UTHRUnited Therapeutics | Healthcare | 1.09% | $108.99 | 1,802 | $1.0M |
of the $116B in 406 An index ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 17.83% |
| 2 | GILD | Gilead Sciences | 6.20% |
| 3 | AMGN | Amgen | 5.55% |
| 4 | VRTX | Vertex Pharmaceuticals | 5.29% |
| 5 | REGN | Regeneron Pharmaceuticals | 4.21% |
| 6 | MRNA | Moderna | 3.46% |
| 7 | BIIB | Biogen | 1.63% |
| 8 | RVMD | Revolution Medicines | 1.51% |
| 9 | ILMN | Illumina | 1.39% |
| 10 | RPRX | Royalty Pharma - | 1.34% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.0826 |
| Mar 25, 2026 | Mar 31, 2026 | $0.0071 |
| Dec 24, 2025 | Dec 31, 2025 | $0.13 |
| Sep 24, 2025 | Sep 30, 2025 | $0.18 |
| Jun 25, 2025 | Jul 1, 2025 | $0.17 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.40 |
| Sep 25, 2024 | Oct 2, 2024 | $0.15 |
| Jun 26, 2024 | Jul 3, 2024 | $0.26 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0403 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0384 |
| Dec 22, 2022 | Dec 30, 2022 | $0.0199 |